MISSISSAUGA, Ontario, Oct. 4, 2018 /CNW/ -- Abbott (NYSE: ABT) announced today the company has received the Health Canada license of its FreeStyle LibreLink mobile app for use with compatible iOS ...
Abbott has received CE Mark clearance for the second generation of its Freestyle Libre device, which will allow the company to make the device available to users in Europe. It will be rolled out ...
FreeStyle Libre is a continuous glucose monitoring (CGM) system. It uses a sensor to read and check a person’s glucose levels. People with diabetes can use FreeStyle Libre to help manage the condition ...
• People can feel more confident managing their diabetes with Abbott’s world-leading continuous glucose monitoring system[1], now with real-time glucose readings and optional alarms. • With continuous ...
Expanded use of FreeStyle Libre system allows health care workers in hospital and professional health care settings to remotely monitor expectant mothers' glucose status to minimize exposure to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results